- Forum Clout
- 17,229
Well, there's Moderna.
Biotech became a lot like horse betting the last 15 years.
New VC firms started popping up everywhere tripping over each other to throw HUNDREDS OF MILLIONS of dollars into tiny startups straight out of MIT grad school that were looking to cure rare diseases that only 30,000 people worldwide have.
The math never added up. Which was why a crash was imminent from the beginning.
Flagship is vested in a lot of small to medium sized companies that may eventually turn a profit, but the idea is to bet on 10 or 20 and hope one becomes Moderna. And they lucked out with Covid.
Another Covid will eventually be engineered to keep the industry afloat, otherwise they all lose money and the economy goes straight down the shitter.
Companies
Flagship Pioneering conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability.
www.flagshippioneering.com
Most of these companies will never send a viable product to market nevermind make a profit. That's the nature of biotech and clinical trials. But if you have enough capital you can blow 90% of it on shit before a unicorn appears.
